Maternal PKU. Pharmaceutical and other advancements | Future Webinar

Tuesday 6th December 2022 14.00 – 15.30 GMT

Want to access this resource?

REGISTER NOW

OR LOGIN IF YOU ARE ALREADY REGISTERED

Learning Objectives

  • To understand how new therapies (e.g. protein substitutes/medical foods, sapropterin, pegvaliase) have impacted management of PKU in pregnancy (MPKU) and lactation.
  • To be able to describe how the use of pegvaliase may be initiated and managed in MPKU from presented case studies.
Register now

Speakers

OTHER RESOURCES YOU MAY BE INTERESTED IN